Expands Drug Recall Power to All Drugs
HR7980-119 · Introduced Mar 18, 2026
Why it matters
If passed, the government could pull more kinds of drugs off the market, and more FDA officials could order those recalls.
What it does
- Lets the health secretary order recalls of all drugs, not only controlled substances
- Lets the power to order recalls go to two FDA center directors or senior officials
- Adds biologics center leaders to the officials who can be given recall power
In committee
Next: a committee vote
- Introduceddone
- Committeecurrent step
- Housenot yet
- Senatenot yet
- Presidentnot yet
About this bill
Would let the health secretary order recalls of all drugs, not just controlled substances, and delegate that power to FDA center directors or senior officials.
Protecting Americans from Unsafe Drugs Act of 2026
Perspectives
💬 The case for
Safety groups would likely say broader recall power helps remove dangerous drugs faster. More officials with that power could speed up action.
💬 The case against
Some drug companies would likely say wider recall power could pull safe products off shelves. They may also worry about less clear limits on who can order recalls.
Sponsored by
Sponsor details for this federal bill are at the source link.
News
Loading coverage…